Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

• Marcus J. G. W. Ladds,
• Ingeborg M. M. van Leeuwen,
• Catherine J. Drummond,
• Su Chu,
• Alan R. Healy,
• Gergana Popova,
• Andrés Pastor Fernández,
• Tanzina Mollick,
• Suhas Darekar,
• Saikiran K. Sedimbi,
• Marta Nekulova,
• Marijke C. C. Sachweh,
• Johanna Campbell,
• Maureen Higgins,
• Chloe Tuck,
• Mihaela Popa,
• Mireia Mayoral Safont,
• Pascal Gelebart,
• Zinayida Fandalyuk,
• Alastair M. Thompson,
• Richard Svensson,
• Anna-Lena Gustavsson,
• Lars Johansson,
• Katarina Färnegårdh,
• Ulrika Yngve,
• Aljona Saleh,
• Martin Haraldsson,
• Agathe C. A. D’Hollander,
• Marcela Franco,
• Yan Zhao,
• Maria Håkansson,
• Björn Walse,
• Karin Larsson,
• Emma M. Peat,
• Vicent Pelechano,
• John Lunec,
• Borivoj Vojtesek,
• Mar Carmena,
• William C. Earnshaw,
• Anna R. McCarthy,
• Nicholas J. Westwood,
• Marie Arsenian-Henriksson,
• David P. Lane,
• Ravi Bhatia,
• Emmet McCormack,
• Sonia Laín

Affiliations

Marcus J. G. W. Ladds

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Ingeborg M. M. van Leeuwen

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Catherine J. Drummond

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Su Chu

Division of Hematology and Oncology, Comprehensive Cancer Center

Alan R. Healy

School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews

Gergana Popova

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Andrés Pastor Fernández

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Tanzina Mollick

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Suhas Darekar

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Saikiran K. Sedimbi

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Marta Nekulova

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Marijke C. C. Sachweh

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Johanna Campbell

Centre for Oncology and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School

Maureen Higgins

Centre for Oncology and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School

Chloe Tuck

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Mihaela Popa

Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen

Mireia Mayoral Safont

Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen

Pascal Gelebart

Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen

Zinayida Fandalyuk

Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen

Alastair M. Thompson

Department of Breast Surgical Oncology, MD Anderson Cancer Center, Holcombe Boulevard

Richard Svensson

Department of Pharmacy, Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University

Anna-Lena Gustavsson

Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet

Lars Johansson

Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet

Katarina Färnegårdh

Drug Discovery and Development Platform, Science for Life Laboratory

Ulrika Yngve

Department of Medicinal Chemistry, Science for Life Laboratories, Uppsala University

Aljona Saleh

Department of Medicinal Chemistry, Science for Life Laboratories, Uppsala University

Martin Haraldsson

Drug Discovery and Development Platform, Science for Life Laboratory

Agathe C. A. D’Hollander

School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews

Marcela Franco

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Yan Zhao

Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University

Maria Håkansson

SARomics Biostructures, Medicon Village

Björn Walse

SARomics Biostructures, Medicon Village

Karin Larsson

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Emma M. Peat

The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh

Vicent Pelechano

SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

John Lunec

Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University

Borivoj Vojtesek

RECAMO, Masaryk Memorial Cancer Institute

Mar Carmena

The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh

William C. Earnshaw

The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh

Anna R. McCarthy

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Nicholas J. Westwood

School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews

Marie Arsenian-Henriksson

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

David P. Lane

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Ravi Bhatia

Division of Hematology and Oncology, Comprehensive Cancer Center

Emmet McCormack

Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen

Sonia Laín

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet